|
| 36978449 | Efficacy of Cefoperazone Sulbactam in Patients with <i>Acinetobacter</i> Infections: A Systematic Review of the Literature. | Antibiotics (Basel) | 2023 |
| 37283634 | Fosfomycin for Non-Urinary Tract Infections: a systematic review. | | 2023 |
| 37025303 | A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools. | Crit Care Explor | 2023 |
| 37379338 | Diagnostic capacities and treatment practices on implantation mycoses: Results from the 2022 WHO global online survey. | | 2023 |
| 36482959 | Role of tigecycline in the treatment of urinary tract infections: a systematic review of published case reports. | | 2022 |
| 32840322 | Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions. | Inflamm Bowel Dis | 2020 |
| 32081980 | Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase. | Scientific Reports | 2020 |
| 30883637 | Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis Complex. | Clinical Infectious Diseases | 2019 |
| 31141643 | Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment. | New England Journal of Medicine | 2019 |
| 31209399 | Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. | Nature Reviews Microbiology | 2019 |
| 31047860 | Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction. | EBioMedicine | 2019 |
| 29846561 | Mycobacterial biomaterials and resources for researchers. | Pathogens and Disease | 2018 |
| 30596645 | Enabling precision medicine via standard communication of HTS provenance, analysis, and results. | PLoS Biol | 2018 |
| 30337678 | Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase. | Scientific Reports | 2018 |
| 30280646 | Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. | N Engl J Med | 2018 |
| 29574065 | Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study. | Lancet Infectious Diseases, The | 2018 |
| 28274744 | Performance of the SAMBA I and II HIV-1 Semi-Q Tests for viral load monitoring at the point-of-care. | Journal of Virological Methods | 2017 |
| 29284687 | A standardised method for interpreting the association between mutations and phenotypic drug resistance in . | European Respiratory Journal | 2017 |
| 28232006 | World TB Day 2017: Advances, Challenges and Opportunities in the "End-TB" Era. | International Journal of Infectious Diseases | 2017 |
| 27789338 | Advancing tuberculosis drug regimen development through innovative quantitative translational pharmacology methods and approaches. | International Journal of Infectious Diseases | 2017 |
| 27986491 | Removing the bottleneck in whole genome sequencing of Mycobacterium tuberculosis for rapid drug resistance analysis: a call to action. | International Journal of Infectious Diseases | 2017 |
| 27872016 | Tuberculosis eradication versus control. | International Journal of Infectious Diseases | 2017 |
| 27397590 | Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project. | Lancet Infectious Diseases, The | 2016 |
| 27016869 | World TB Day 2016: reflections on the global TB emergency. | Lancet Respiratory Medicine,The | 2016 |
| 27036358 | Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. | Lancet Infectious Diseases, The | 2016 |
| 26409271 | Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines. | Clinical Infectious Diseases | 2015 |
| 25765105 | Target product profile of a molecular drug-susceptibility test for use in microscopy centers. | Journal of Infectious Diseases | 2015 |
| 25765106 | Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis. | Journal of Infectious Diseases | 2015 |
| 25765104 | Defining the needs for next generation assays for tuberculosis. | Journal of Infectious Diseases | 2015 |
| 25765103 | Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. | Journal of Infectious Diseases | 2015 |
| 26717411 | HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing. | PLoS One | 2015 |
| 26184493 | Towards host-directed therapies for tuberculosis. | Nat Rev Drug Discov | 2015 |
| 26629499 | A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers. | eBioMedicine | 2015 |
| 26409286 | Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done. | Clinical Infectious Diseases | 2015 |
| 26409281 | Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update. | Clinical Infectious Diseases | 2015 |
| 26409275 | Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform. | Clinical Infectious Diseases | 2015 |
| 24670623 | Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines. | Lancet Infectious Diseases, The | 2014 |
| 24447533 | Development of a contemporary globally diverse HIV viral panel by the EQAPOL program. | J Immunol Methods | 2014 |
| 24717627 | Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. | Lancet Respiratory Medicine,The | 2014 |
| 24717619 | Totally-drug-resistant tuberculosis: hype versus hope. | Lancet Respiratory Medicine,The | 2014 |
| 24670627 | New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. | Lancet Infectious Diseases, The | 2014 |
| 23531385 | Zero deaths from tuberculosis: progress, reality, and hope. | Lancet Infectious Diseases, The | 2013 |
| 23531393 | Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. | Lancet Infectious Diseases, The | 2013 |
| 23531392 | Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. | Lancet Infectious Diseases, The | 2013 |
| 23531391 | Drug-resistant tuberculosis: time for visionary political leadership. | Lancet Infectious Diseases, The | 2013 |
| 23531389 | Tuberculosis biomarkers discovery: developments, needs, and challenges. | Lancet Infectious Diseases, The | 2013 |
| 23531388 | Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. | Lancet Infectious Diseases, The | 2013 |
| 22206265 | Workshop summary: Novel biomarkers for HIV incidence assay development. | AIDS Research and Human Retroviruses | 2012 |
| 22402038 | Perspectives on introduction and implementation of new point-of-care diagnostic tests. | Journal of Infectious Diseases | 2012 |
| 22476720 | Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. | Journal of Infectious Diseases | 2012 |